A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
Karim Fizazi(Institut Gustave Roussy), Aline Maillard(Institut Gustave Roussy), Nicolas Penel, G. Baciarello, Djelila Allouache(Centre François Baclesse), Gedske Daugaard(Rigshospitalet), A. van de Wouw, G. Soler, Élodie Vauléon(Centre Eugène Marquis), L. Chaigneau(Centre Hospitalier Universitaire de Besançon), René A. J. Janssen, F. Losa Gaspà, Rafael Morales‐Barrera, Carmen Balañá, Diégo Tosi(Institut de Recherche en Cancérologie de Montpellier), Bruno Chauffert(Centre Hospitalier Universitaire Amiens-Picardie), Claudia Schnabel, Géraldine Martineau, S. Culine(Hôpital Saint-Louis), Isabelle Borget(Service de la Santé Publique)
Cited by 245Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis